Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
LIPLASOME PHARMA ApS
APS
Active
Reklamebeskyttelse
CVR 29428514
Tabletvej 1, 7100
Vejle
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2006 · 20 years old
2 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
LIPLASOME PHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
HH
Hans-Henrik Horsted Eriksen
Chief Executive Officer
Chief Executive Officer
2012
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (2)
SK
Sanjay Kumar Sehgal
Board of Directors
Board of Directors
2016
JR
John Riis Mortensen
Chairman
Chairman
2012
Former (8)
CB
Claus Bagger-Sørensen
Board of Directors
Board of Directors
2006 – 2012
TV
Torben Vilsgaard
Board of Directors
Board of Directors
2011 – 2012
OL
Ole Lund
Board of Directors
Board of Directors
2006 – 2011
DM
Duncan Moore
Board of Directors
Board of Directors
2012 – 2016
HB
Holger Bagger-Sørensen
Chairman
Chairman
2006 – 2012
TB
Torben Brøgger-Mikkelsen
Board of Directors
Board of Directors
2006 – 2012
SB
Steen Bagger-Sørensen
Board of Directors
Board of Directors
2006 – 2012
PB
Peter Buhl
Board of Directors
Board of Directors
2008 – 2016
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
BAGGER-SØRENSEN & CO. A/S
Company
90–99.99%
90–99.99%
2022
VECATA INVEST ApS
Company
90–99.99%
90–99.99%
2012
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on LIPLASOME PHARMA ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network